Delaware Cannabis Industry Overview

Delaware's recreational market launched August 1, 2025 with $29.3 million in sales through its first seven months. With 125 licenses awarded but no new stores open yet, the market is still in its earliest stages.

Last verified: March 2026

Market Launch and Early Performance

Recreational cannabis sales in Delaware began on August 1, 2025, when existing medical compassion centers were authorized to begin serving adult-use customers. The opening weekend (August 1–3) generated $625,000 in sales — a strong start for a state with fewer than one million residents.

Through the first seven months of recreational sales:

Category Revenue
Recreational sales $29.3 million
Medical sales $43.1 million
Combined total $72.4 million
Estimated tax revenue (rec only) ~$4.4 million

A notable dynamic: medical sales still outpace recreational. This is unusual — in most states, recreational quickly overtakes medical after launch. Delaware's tax exemption for medical patients (saving 15% on every purchase) gives patients a strong financial incentive to keep their cards, which may explain the resilience of medical revenue.

Why Revenue Is Below Projections

The state projected $42 million in annual recreational tax revenue. Through seven months, actual tax collection sits at approximately $4.4 million, on pace to fall well short. The primary driver is limited retail access:

  • Only existing compassion centers are currently selling recreational cannabis
  • None of the 30 new retail licenses awarded in the 2024 lottery have resulted in operational stores
  • New licensees have an 18-month window to open, with the first expected mid-to-late 2026
  • Full market buildout is not anticipated until 2027

Limited storefront competition has also kept prices elevated compared to neighboring states, driving some Delaware consumers to purchase in Maryland or New Jersey instead.

The 125-License Framework

Delaware's initial cannabis market is structured around 125 licenses across four categories: 30 retail, 60 cultivation, 30 manufacturing, and 5 testing. These licenses are divided among open, social equity, and microbusiness applicants.

The OMC received 1,269 applications during the August–September 2024 window, generating more than $4 million in application fees. Licenses were awarded by lottery in October and December 2024.

As of March 2026, 16 conditional retail licenses have been formally issued, but buildout timelines vary. The constraint is not regulatory — it's the reality of securing real estate, completing construction, passing inspections, and training staff in a brand-new market.

The I-95 Corridor Factor

Delaware's position on the I-95 corridor gives it unique market dynamics. The state shares borders with Pennsylvania (medical-only), New Jersey (recreational since 2022), and Maryland (recreational since 2023). This creates:

  • PA visitors: Pennsylvania residents without recreational access represent a significant potential customer base, especially in northern Delaware near Wilmington
  • NJ and MD competition: Delaware consumers near the borders can easily cross into states with more established markets and potentially lower prices
  • Tourism potential: Delaware beach communities (Rehoboth, Dewey, Lewes) draw millions of summer visitors who may purchase cannabis during their stay

What to Watch in 2026–2027

  • New retail openings: The first new dispensaries outside the legacy compassion center system are expected mid-to-late 2026
  • Price competition: Additional retailers should drive prices down toward regional norms
  • Revenue ramp: Tax revenue should accelerate as the market matures and access improves
  • Additional licensing rounds: The OMC has not yet announced whether or when it will issue licenses beyond the initial 125